344 related articles for article (PubMed ID: 12115879)
1. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
2. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
3. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
Natkunam Y; Warnke RA; Montgomery K; Falini B; van De Rijn M
Mod Pathol; 2001 Jul; 14(7):686-94. PubMed ID: 11455001
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
[TBL] [Abstract][Full Text] [Related]
5. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
6. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders.
Abed N; Casper JT; Camitta BM; Margolis D; Trost B; Orentas R; Chang CC
Bone Marrow Transplant; 2004 Feb; 33(3):321-7. PubMed ID: 14688820
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic lymphoma: a clinicopathologic correlation.
Folk GS; Abbondanzo SL; Childers EL; Foss RD
Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
12. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
14. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
[TBL] [Abstract][Full Text] [Related]
16. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
17. Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells.
Meyerson HJ; Bailey J; Miedler J; Olobatuyi F
Cytometry B Clin Cytom; 2011 Mar; 80(2):71-82. PubMed ID: 21337490
[TBL] [Abstract][Full Text] [Related]
18. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.
Valdez R; Finn WG; Ross CW; Singleton TP; Tworek JA; Schnitzer B
Am J Clin Pathol; 2001 Nov; 116(5):683-90. PubMed ID: 11710684
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
20. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]